Mylan launches Canadian adherence program for Mavik patients

TORONTO — In an attempt to boost adherence for patients taking the hypertension medication Mavik, Mylan EPD in Canada has launched its MyFreshStart program. Offered through Canadian pharmacies, the program provides patients with information about hypertension and such activities as quizzes and sweepstatkes to engage them and drive compliant behaviors like regularly refilling their prescription and taking it as prescribed. 

 

“We're excited to announce the launch of MyFreshStart for pharmacists and their patients,” Mylan EPD in Canada head Barry Hayter said. “We know that nonadherence negatively impacts health outcomes, and we believe this program provides pharmacists with a meaningful platform to discuss the importance of compliance with their patients. This new resource reinforces Mylan's commitment to expand access to high quality medicine as we innovate to meet unmet needs.”

 

MyFreshStart is being offered at no cost to Canada’s pharmacies, where patients will enroll. Once enrolled, patients can access the platform to start earning points that can be redeemed for health-related items. Pharmacies can reach out with questions to 844-596-9526.